Clinical Trial Update: Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ABS-201 evaluating single and multiple ascending doses in healthy adults with and without androgenetic alopecia; Phase 1/Phase 2, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• ABS-201

Snippet

Sponsor: Absci Pty Ltd. | Conditions: Androgenetic Alopecia (AGA), Healthy Volunteers - Male and Female | Phase 1, Phase 2 | Status: RECRUITING